Report Sections

See All Reports

  • HP:0002020: Gastroesophageal reflux
  • Pneumonia (312) Abnormality of the cardiovascular system (29) Neoplasm (27) Respiratory tract infection (27) Hypoxemia (22) Depressivity (21) Diabetes mellitus (19) Acute kidney injury (19) Abnormal lung morphology (19) Thromboembolism (17) Hypertension (16) Anosmia (14) Myocardial infarction (14) Abnormality of coagulation (14) Stroke (13) Pulmonary embolism (13) Arthritis (12) Leukemia (12) Interstitial pneumonitis (12) Autistic behavior (11) Mental deterioration (11) Deep venous thrombosis (10) Type II diabetes mellitus (10) Pulmonary obstruction (10) Crohn's disease (10) Abnormality of the kidney (9) Autism (9) Obesity (9) Congestive heart failure (9) Chronic pulmonary obstruction (9) Chronic pain (9) Rheumatoid arthritis (8) Abnormality of the liver (8) Respiratory distress (8) Pulmonary fibrosis (8) Colitis (8) Myocarditis (8) Carcinoma (8) Ulcerative colitis (8) Behavioral abnormality (7) Dementia (7) Infertility (7) Inflammation of the large intestine (7) Pulmonary insufficiency (7) Low levels of vitamin D (7) Neoplasm of the lung (7) Type I diabetes mellitus (7) Psychosis (6) Coronary artery atherosclerosis (6) Lymphoma (6) Abnormality of the gastrointestinal tract (6) Chronic kidney disease (6) Sepsis (6) Renal insufficiency (5) Lymphopenia (5) Gastroparesis (5) Immunodeficiency (5) Systemic lupus erythematosus (5) Breast carcinoma (5) Peripheral arterial stenosis (5) Allergy (5) Encephalopathy (4) Hepatic fibrosis (4) Cardiac arrest (4) Dysphagia (4) Asthma (4) Alzheimer disease (4) Osteoarthritis (4) Neoplasm of the pancreas (4) Autoimmunity (4) Disseminated intravascular coagulation (4) Attention deficit hyperactivity disorder (4) Sleep apnea (4) Prostate cancer (4) Neoplasm of head and neck (4) Addictive behavior (4) Insomnia (4) Obsessive-compulsive behavior (3) Seizure (3) Cardiomyopathy (3) Weight loss (3) Fever (3) Migraine (3) Pulmonary arterial hypertension (3) Bronchiectasis (3) Obstructive sleep apnea (3) Colon cancer (3) Reduced factor VIII activity (3) Malnutrition (3) Knee osteoarthritis (3) Lymphoid leukemia (3) Renal cell carcinoma (3) Arrhythmia (3) Fatigue (3) Endometriosis (3) Non-small cell lung carcinoma (3) Neuroendocrine neoplasm (3) Hypercoagulability (3) Schizophrenia (3) Hearing impairment (2) Visual impairment (2) Conjunctivitis (2) Uveitis (2) Agoraphobia (2) Abnormality of the endocrine system (2) Abnormal heart morphology (2) Tachycardia (2) Angina pectoris (2) Gastroesophageal reflux (2) Neurodegeneration (2) Abnormal intestine morphology (2) Alopecia of scalp (2) Mutism (2) Headache (2) Transient ischemic attack (2) Hyperkinetic movements (2) Polyphagia (2) Atherosclerosis (2) Hypoventilation (2) Myelodysplasia (2) Psoriasiform dermatitis (2) Paroxysmal atrial fibrillation (2) Acute myeloid leukemia (2) Lymphoproliferative disorder (2) Myeloproliferative disorder (2) Multiple myeloma (2) Intervertebral disc degeneration (2) Stridor (2) Cystoid macular edema (2) Hemeralopia (2) Cutaneous melanoma (2) Arteritis (2) Glioblastoma multiforme (2) Cervix cancer (2) Pulmonary edema (2) Ovarian neoplasm (2) Angioedema (2) Mania (2) Neoplasm of the large intestine (2) Urinary retention (1) Urinary incontinence (1) Nephritis (1) Menorrhagia (1) Xerostomia (1) Hypogeusia (1) Conductive hearing impairment (1) Abnormality of the eye (1) Cataract (1) Amblyopia (1) Periodontitis (1) Enuresis (1) Hypoparathyroidism (1) Adrenal insufficiency (1) Hyperaldosteronism (1) Osteopenia (1) Abnormality of the skin (1) Jaundice (1) Lymphedema (1) Angiokeratoma corporis diffusum (1) Keratoconjunctivitis (1) Spasticity (1) Hemiparesis (1) Polyneuropathy (1) Syncope (1) Meningitis (1) Cerebral hemorrhage (1) Abnormal joint morphology (1) Hepatic steatosis (1) Hepatic failure (1) Hepatocellular carcinoma (1) Premature birth (1) Sudden cardiac death (1) Aortic valve stenosis (1) Bradycardia (1) Torsade de pointes (1) Atrioventricular block (1) Pancreatitis (1) Abnormality of blood and blood-forming tissues (1) Gout (1) Diarrhea (1) Anorexia (1) Esophageal varix (1) Hypothermia (1) Apnea (1) Status epilepticus (1) Subarachnoid hemorrhage (1) Memory impairment (1) Difficulty walking (1) Encephalitis (1) Waddling gait (1) Increased intracranial pressure (1) Celiac disease (1) Biliary cirrhosis (1) Hypotension (1) Osteomyelitis (1) Squamous cell carcinoma (1) Central apnea (1) Hypokalemia (1) Hyponatremia (1) Hyperphosphatemia (1) Skeletal muscle atrophy (1) Male infertility (1) Spondylolisthesis (1) Myalgia (1) Back pain (1) Low back pain (1) Muscular dystrophy (1) Neonatal death (1) Thrombophlebitis (1) Chronic bronchitis (1) Ventricular tachycardia (1) Coronary artery stenosis (1) Chronic lymphatic leukemia (1) Hypersensitivity pneumonitis (1) Intraalveolar phospholipid accumulation (1) Abnormal anterior horn cell morphology (1) Amyotrophic lateral sclerosis (1) Neoplasm of the skin (1) Female infertility (1) Benign prostatic hyperplasia (1) Hip osteoarthritis (1) Stomatitis (1) Uterine neoplasm (1) Intestinal atresia (1) Inflammatory abnormality of the skin (1) Sinus tachycardia (1) Bronchiolitis (1) Postprandial hyperglycemia (1) Hepatitis (1) Erythroid hypoplasia (1) Hodgkin lymphoma (1) B-cell lymphoma (1) Myeloid leukemia (1) Chronic myelomonocytic leukemia (1) Morphea (1) Bronchitis (1) Hypercapnia (1) Pain (1) Retinal vein occlusion (1) Vasovagal syncope (1) Neonatal asphyxia (1) Dyspareunia (1) Heart murmur (1) Cardiogenic shock (1) Cholangitis (1) Cholangiocarcinoma (1) Small cell lung carcinoma (1) Vulvar neoplasm (1) Neonatal sepsis (1) Glue ear (1) Subdural hemorrhage (1) Endocarditis (1) Toxemia of pregnancy (1) Myositis (1) Vaginal neoplasm (1) Cellulitis (1) Self-injurious behavior (1) Bulimia (1) Neoplasm of the rectum (1) Chest pain (1) Atelectasis (1) Lymphocytosis (1) Polymenorrhea (1)

    HP:0002020: Gastroesophageal reflux

    Developed by Shray Alag, The Harker School
    Sections: Correlations, Clinical Trials, and HPO

    Correlations computed by analyzing all clinical trials.

    Navigate: Clinical Trials and HPO


    Correlated Drug Terms (5)


    Name (Synonyms) Correlation
    drug1608 IW-3718 Wiki 0.71
    drug1069 Dipyridamole ER 200mg/ Aspirin 25mg orally/enterally AND Standard of care Wiki 0.71
    drug2249 None - NA Wiki 0.71
    Name (Synonyms) Correlation
    drug4034 placebo Wiki 0.19
    drug3231 Standard of care Wiki 0.15

    Correlated MeSH Terms (4)


    Name (Synonyms) Correlation
    D005764 Gastroesophageal Reflux NIH 1.00
    D004942 Esophagitis, Peptic NIH 0.71
    D004932 Esophageal and Gastric Varices NIH 0.71
    Name (Synonyms) Correlation
    D003108 Colonic Diseases NIH 0.71

    Correlated HPO Terms (1)


    Name (Synonyms) Correlation
    HP:0002040 Esophageal varix HPO 0.71

    Clinical Trials

    Navigate: Correlations   HPO

    There are 2 clinical trials


    1 A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Trial of Oral IW-3718 Administered to Patients With Gastroesophageal Reflux Disease While Receiving Proton Pump Inhibitors

    The objective of this study is to evaluate the safety and efficacy of IW-3718 administered to patients with GERD who continue to have persistent symptoms, such as heartburn and regurgitation, while receiving once-daily (QD), standard-dose proton pump inhibitors (PPIs).

    NCT03561090
    Conditions
    1. Gastroesophageal Reflux Disease (GERD)
    Interventions
    1. Drug: IW-3718
    2. Drug: placebo
    MeSH:Gastroesophageal Reflux Esophagitis, Peptic
    HPO:Gastroesophageal reflux

    Primary Outcomes

    Measure: Proportion of Overall Heartburn Responders

    Time: Week 8

    Secondary Outcomes

    Measure: Proportion of Overall Heartburn Responders Among Participants With a Baseline Weekly Heartburn Severity Score (WHSS) ≥ 3

    Time: Week 8

    Measure: Percent Change From Baseline to Week 8 in WHSS

    Time: Baseline, Week 8

    Measure: Percent Change From Baseline to Week 8 in Weekly Regurgitation Frequency Score (WRFS)

    Time: Baseline, Week 8

    Measure: Proportion of Heartburn-Free (Daily Heartburn Severity Score [DHSS]=0) Days During the 8-Week Treatment Period

    Time: up to Week 8

    Measure: Proportion of Overall Regurgitation Responders

    Time: Week 8

    Measure: Proportion of Days When Heartburn Did Not Occur (DHSS=0) or Was Very Mild (DHSS=1) During the 8-Week Treatment Period

    Time: Week 8

    Measure: Proportion of Days When Regurgitation Did Not Occur (Daily Regurgitation Frequency Scores [DRFS]=0) or Rarely Occurred (DRFS=1) During the 8-Week Treatment Period

    Time: Week 8

    Measure: Proportion of Regurgitation-Free (DRFS=0) Days During the 8-Week Treatment Period

    Time: Week 8

    Measure: Change From Baseline to Week 8 in Each Modified Reflux Symptom Questionnaire Electronic Diary (mRESQ) Item

    Time: Baseline, Week 8

    Measure: Proportion of Nights With Difficulty Falling Asleep Due to GERD During the 8-Week Treatment Period

    Time: Week 8

    Measure: Proportion of Days With Nighttime Awakening Due to GERD During the 8-Week Treatment Period

    Time: Week 8

    Measure: Number of Degree of Relief (of Heartburn/Regurgitation/Overall GERD Symptoms) Responders

    Time: up to Week 8

    Measure: Change From Baseline to Week 8 in Heartburn/Regurgitation/Overall GERD Symptoms Bothersomeness

    Time: Baseline, Week 8

    Measure: Proportion of Days With Rescue Medication Use During the 8-Week Treatment Period

    Time: up to Week 8
    2 Endoscopy-related Phone Consultation During the COVID-19 Outbreak: Impact on Attendance and Patient/Consultant Perspectives From a Tertiary Australian Hospital

    The aim of this study is to evaluate patient and consultant experiences with phone consultations for endoscopy-related outpatient appointments during the COVID-19 outbreak.

    NCT04344964
    Conditions
    1. Colon Polyp
    2. Colon Disease
    3. Reflux, Gastroesophageal
    4. Varices, Esophageal
    Interventions
    1. Other: None - NA
    MeSH:Colonic Diseases Gastroesophageal Reflux Esophageal and Gastric Varices
    HPO:Esophageal varix Gastric varix Gastroesophageal reflux

    Primary Outcomes

    Description: percentage of patients that did not answer phone calls (at least 3 calls) or with documented FTA for the retrospective group.

    Measure: Failed to attend patients

    Time: 2 months

    Secondary Outcomes

    Description: Assessed through an online/hardcopy questionnaire based on previous studies on telehealth (adapted from Barsom et al. 2020 - MSF and PAT-VC questionnaires). These are mostly Likert-scale response mode statements.

    Measure: Patient satisfaction with the phone consult

    Time: 2 months

    Description: Assessed through an online/hardcopy questionnaire based on previous studies on telehealth (adapted from Barsom et al. 2020). These are mostly Likert-scale response mode statements.

    Measure: Consultant satisfaction with the phone consult

    Time: 2 months

    HPO Nodes


    HP:0002020: Gastroesophageal reflux
    Genes 347
    PPM1D DNM1 SHANK3 CCDC47 CTBP1 COL13A1 DHCR7 LIMK1 VAMP1 LBR ELP1 SCN3A KCNAB2 GPHN SLC1A4 SLC13A5 AFF4 SEC63 FOXG1 FGFR3 ACTL6B POLG TCF4 COG7 ELN CNKSR2 STAG1 SMG9 SLC1A2 ATP6V1A ATRX RRM2B AMER1 NIPBL SAMD9 RAI1 SMC1A SALL1 TYMP PRDM16 CHMP1A FGFRL1 SCN8A FAM13A STN1 DSP SYNJ1 GMNN CDKL5 WWOX NFIX CCR6 TRAK1 RRM2B POLG2 PRKCSH RREB1 ALDH18A1 MCEE SLC5A7 ARFGEF2 PHGDH SEMA3E NUP62 ADNP NTRK2 LONP1 WDR26 CHD7 PHOX2B ORC6 SMC3 SHANK3 GABRA2 RET NALCN KMT2A RAI1 HLA-DRB1 SLC35A2 KAT6A TFAP2A CAMK2B RHBDF2 FARSB HDAC8 NIPBL FLNA COL13A1 RERE MYMK ASXL1 NRXN1 ADAR MECP2 MAP3K7 TMTC3 TOP3A MLXIPL CDKL5 CACNA1B ASCC1 HLA-DQA1 IRF5 MECP2 SFTPC ABCA3 SLC19A2 KIAA0319L SKI RAD21 CNTNAP1 PIGN PIGN GABBR2 NALCN ARVCF PAK1 FLCN ATRX KIAA0586 RERE FCSK SFTPA1 KLHL7 LAMA2 SSR4 POLG IQSEC2 SKI SLC2A10 GEMIN4 HNRNPH2 ALDH18A1 POLG2 BAZ1B RTEL1 TAF1 CYFIP2 GALC ASCL1 EXT2 SFTPA2 NTNG1 TSPYL1 ASXL1 LRP5 OCRL ZSWIM6 ATP7A SLC46A1 NEXMIF TBX4 AP3B2 EEF1A2 GP1BB KCNB1 TCF4 ATP11A LTBP4 NEDD4L SMC1A TECPR2 NONO GTF2IRD1 ADAMTS2 UFD1 SHROOM4 LETM1 MUC5B STAG1 STXBP1 DDC TRIP4 RAD21 NUS1 HLA-DQB1 CACNA1A RPL10 MYO9A PORCN SH2B1 MECP2 TWNK RFC2 ATN1 SLC6A5 IRF5 AGRN GABRG2 CTHRC1 CRLF1 GRIN2D ADAT3 SNAP25 SYT1 SLC9A6 NONO CAV1 GTF2I TWIST1 MID1 ATAD1 EXT2 SMC3 ARNT2 NUP214 HRAS CLTC PIGT NSD2 STXBP1 DEAF1 DHCR7 PIEZO2 TERC BRAF CLIP2 PSPH NPHS1 POGZ COMT NECAP1 SEC23A SZT2 NRXN1 DDOST HLA-DRB1 JMJD1C EHMT1 AARS1 FMR1 WNK1 UBA5 KIF1A SOX5 ARV1 SMC1A PCGF2 RPL10 TSPYL1 HIRA SLC6A3 MRPS34 PUF60 RETREG1 SYT1 FOXG1 RNF125 YWHAG FLNA CPLX1 PGM3 NOS1 AFF4 SLC25A1 ORC4 TBX1 PARS2 TBC1D24 KAT6B EBF3 ATRX ABCD4 ORC1 PYCR1 RERE WASHC5 FLII SETD5 NEXMIF MAP3K7 CCDC22 PACS1 TRAPPC12 KCNA2 ELP1 ELN POGZ DDOST PPP3CA PARN MED12 ASPA FBXL4 GABRB2 SLC25A24 WHCR CNTNAP2 CCN2 CHAMP1 CHAT ATP6 TBL2 CTCF GLRB ARF1 SLC18A3 PIEZO1 TBX1 CAV1 GABRD GLRA1 USP7 KMT2A ERMARD PIGN SCN9A FGF12 RPL10 CSPP1 ATRX DHDDS CLCN4 SLC35A2 PSAP FBN1 SEC24C GABRA5 CAMTA1 TCF4 HIVEP2 MAGEL2 MECP2 CCR6 SKI STAC3 UBA5 RAI1 KCNA2 HCN1 SYT2 SNRPB SLC6A3 MSR1 TERT TRMT10C SLC25A4 CDC6 SON MAP1B SYNGAP1 DPP9 CCN2 HDAC8 MEIS2 ARID2
    Protein Mutations 1
    D961H
    SNP 0

    HPO

    Alphabetical listing of all HPO terms. Navigate: Correlations   Clinical Trials


    HPO Nodes


    HP:0002020: Gastroesophageal reflux
    Genes 347
    PPM1D DNM1 SHANK3 CCDC47 CTBP1 COL13A1 DHCR7 LIMK1 VAMP1 LBR ELP1 SCN3A KCNAB2 GPHN SLC1A4 SLC13A5 AFF4 SEC63 FOXG1 FGFR3 ACTL6B POLG TCF4 COG7 ELN CNKSR2 STAG1 SMG9 SLC1A2 ATP6V1A ATRX RRM2B AMER1 NIPBL SAMD9 RAI1 SMC1A SALL1 TYMP PRDM16 CHMP1A FGFRL1 SCN8A FAM13A STN1 DSP SYNJ1 GMNN CDKL5 WWOX NFIX CCR6 TRAK1 RRM2B POLG2 PRKCSH RREB1 ALDH18A1 MCEE SLC5A7 ARFGEF2 PHGDH SEMA3E NUP62 ADNP NTRK2 LONP1 WDR26 CHD7 PHOX2B ORC6 SMC3 SHANK3 GABRA2 RET NALCN KMT2A RAI1 HLA-DRB1 SLC35A2 KAT6A TFAP2A CAMK2B RHBDF2 FARSB HDAC8 NIPBL FLNA COL13A1 RERE MYMK ASXL1 NRXN1 ADAR MECP2 MAP3K7 TMTC3 TOP3A MLXIPL CDKL5 CACNA1B ASCC1 HLA-DQA1 IRF5 MECP2 SFTPC ABCA3 SLC19A2 KIAA0319L SKI RAD21 CNTNAP1 PIGN PIGN GABBR2 NALCN ARVCF PAK1 FLCN ATRX KIAA0586 RERE FCSK SFTPA1 KLHL7 LAMA2 SSR4 POLG IQSEC2 SKI SLC2A10 GEMIN4 HNRNPH2 ALDH18A1 POLG2 BAZ1B RTEL1 TAF1 CYFIP2 GALC ASCL1 EXT2 SFTPA2 NTNG1 TSPYL1 ASXL1 LRP5 OCRL ZSWIM6 ATP7A SLC46A1 NEXMIF TBX4 AP3B2 EEF1A2 GP1BB KCNB1 TCF4 ATP11A LTBP4 NEDD4L SMC1A TECPR2 NONO GTF2IRD1 ADAMTS2 UFD1 SHROOM4 LETM1 MUC5B STAG1 STXBP1 DDC TRIP4 RAD21 NUS1 HLA-DQB1 CACNA1A RPL10 MYO9A PORCN SH2B1 MECP2 TWNK RFC2 ATN1 SLC6A5 IRF5 AGRN GABRG2 CTHRC1 CRLF1 GRIN2D ADAT3 SNAP25 SYT1 SLC9A6 NONO CAV1 GTF2I TWIST1 MID1 ATAD1 EXT2 SMC3 ARNT2 NUP214 HRAS CLTC PIGT NSD2 STXBP1 DEAF1 DHCR7 PIEZO2 TERC BRAF CLIP2 PSPH NPHS1 POGZ COMT NECAP1 SEC23A SZT2 NRXN1 DDOST HLA-DRB1 JMJD1C EHMT1 AARS1 FMR1 WNK1 UBA5 KIF1A SOX5 ARV1 SMC1A PCGF2 RPL10 TSPYL1 HIRA SLC6A3 MRPS34 PUF60 RETREG1 SYT1 FOXG1 RNF125 YWHAG FLNA CPLX1 PGM3 NOS1 AFF4 SLC25A1 ORC4 TBX1 PARS2 TBC1D24 KAT6B EBF3 ATRX ABCD4 ORC1 PYCR1 RERE WASHC5 FLII SETD5 NEXMIF MAP3K7 CCDC22 PACS1 TRAPPC12 KCNA2 ELP1 ELN POGZ DDOST PPP3CA PARN MED12 ASPA FBXL4 GABRB2 SLC25A24 WHCR CNTNAP2 CCN2 CHAMP1 CHAT ATP6 TBL2 CTCF GLRB ARF1 SLC18A3 PIEZO1 TBX1 CAV1 GABRD GLRA1 USP7 KMT2A ERMARD PIGN SCN9A FGF12 RPL10 CSPP1 ATRX DHDDS CLCN4 SLC35A2 PSAP FBN1 SEC24C GABRA5 CAMTA1 TCF4 HIVEP2 MAGEL2 MECP2 CCR6 SKI STAC3 UBA5 RAI1 KCNA2 HCN1 SYT2 SNRPB SLC6A3 MSR1 TERT TRMT10C SLC25A4 CDC6 SON MAP1B SYNGAP1 DPP9 CCN2 HDAC8 MEIS2 ARID2
    Protein Mutations 1
    D961H
    SNP 0

    Reports

    Data processed on September 26, 2020.

    An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.

    Drug Reports   MeSH Reports   HPO Reports  

    Interventions

    4,180 reports on interventions/drugs

    MeSH

    691 reports on MeSH terms

    HPO

    263 reports on HPO terms

    All Terms

    Alphabetical index of all Terms

    Google Colab

    Python example via Google Colab Notebook